Title of Invention | ANTI-IL-17A /IL-17F CROSS-REACTIVE ANTIBODIES |
---|---|
Abstract | This invention provides fully human monoclonal antibodies that recognize IL-17F, the IL-17F homodimer, IL-17A, the IL-17A homodimer, and/or the heterodimeric IL-17A/IL-17F protein complex. The invention further provides methods of using such monoclonal antibodies as a therapeutic, diagnostic, and prophylactic. |
Full Text |
---|
Patent Number | 279899 | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Indian Patent Application Number | 7429/DELNP/2010 | ||||||||||||
PG Journal Number | 05/2017 | ||||||||||||
Publication Date | 03-Feb-2017 | ||||||||||||
Grant Date | 01-Feb-2017 | ||||||||||||
Date of Filing | 21-Oct-2010 | ||||||||||||
Name of Patentee | NOVIMMUNE SA | ||||||||||||
Applicant Address | 14 CH. DES AULX PLAN LES OUATES CH-1223 GENEVA (CH). | ||||||||||||
Inventors:
|
|||||||||||||
PCT International Classification Number | C07K 16/00 | ||||||||||||
PCT International Application Number | PCT/IB2009/005796 | ||||||||||||
PCT International Filing date | 2009-05-05 | ||||||||||||
PCT Conventions:
|